Nanotechnology Now - Press Release: "Advances in Synthetic Chemistry 2008"

Home > Press > Advances in Synthetic Chemistry 2008

Abstract:
Select Biosciences is proud to announce their first conference devoted to Advances in Synthetic Chemistry. The meeting will focus primarily on Flow Chemistry and Microwave-Assisted Organic Synthesis.

Advances in Synthetic Chemistry 2008

Frankfurt, Germany | Posted on December 19th, 2007

Alongside an exhibition of selected scientific posters and service providers, Select Biosciences is organizing a two day conference gathering some of the most influential researchers in the field including :

Oliver Kappe, Associate Professor of Chemistry, University of Graz
Ferenc Darvas, President, Thales Nanotechnology
Fredrik Almqvist, Research Director, Biological Chemistry, Umeå University
Mark Bagley, Senior Lecturer, University of Cardiff
Ian Baxendale, Research Fellow, University of Cambridge
Carsten Bolm, Professor, RWTH Aachen
Maurizio Botta, Professor, University of Siena
Marcus Koppitz, Senior Scientist, Bayer Schering Pharma
Fernando Langa, Professor, University Castilla-La Mancha
Vincenzo Santagada, Professor of Medicinal Chemistry, University of Naples
Peter Seeberger, Professor, ETH Zurich
Brian Warrington, Director, BB Consultants Ltd
Catherine Smith, University of Cambridge
Mark Bagley, Senior Lecturer, University of Cardiff
Sven Schroeder, Professor, University of Manchester
And many more...

To guarantee a high attendance Select Biosciences will maintain their traditional low registration fees and group booking discounts. Furthermore, to encourage educational development, special priced passes are available to students as are one-day passes for the busy researcher who can't spare time for the full two days.

####

About Select Biosciences Ltd.
The conferences division of Select Biosciences Ltd. is focused on organizing specialist biomedical meetings each year. Experts from both academia and commerce are invited to present timely information from current research through to commercial implementation of new technologies. These events also provide a unique networking facility and the opportunity to reach a highly targeted scientific audience.

For more information, please click here

Contacts:
Sara Sharpe

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: